Anterogen.Co.,Ltd. (KOSDAQ:065660)
South Korea flag South Korea · Delayed Price · Currency is KRW
25,700
+1,050 (4.26%)
Jun 12, 2026, 3:30 PM KST

Anterogen.Co.,Ltd. Revenue

Anterogen.Co.,Ltd. had revenue of 2.12B KRW in the quarter ending March 31, 2026, with 32.49% growth. This brings the company's revenue in the last twelve months to 8.06B, up 15.06% year-over-year. In the year 2025, Anterogen.Co.,Ltd. had annual revenue of 7.54B with 8.71% growth.

Revenue (ttm)
8.06B
Revenue Growth
+15.06%
P/S Ratio
31.92
Revenue / Employee
n/a
Employees
n/a
Market Cap
257.16B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20257.54B603.60M8.71%
Dec 31, 20246.93B432.62M6.66%
Dec 31, 20236.50B-90.76M-1.38%
Dec 31, 20226.59B-1.53B-18.85%
Dec 31, 20218.12B3.97B95.64%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
EASY BIO,Inc.490.70B
Bioneer338.01B
BINEX164.00B
GC Cell163.35B
JETEMA,77.07B
MEDIPOST73.90B
HLB Therapeutics67.56B
SillaJen10.92B
Revenue Rankings